| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |